Literature DB >> 23238071

[Conjunctival limbal autograft versus simple excision with intra-operative mitomycin C in pterygium surgery: a comparative study].

I Malek1, I Zghal, A Chebbi, Z Lajili, C Boujemaa, L Nacef, H Bouguila, S Saida Ayed.   

Abstract

PURPOSE: The purpose of our study is to evaluate the long-term anatomical and functional results of conjunctival-limbal autograft (AGCL) compared to simple excision with intraoperative mitomycin C. PATIENTS AND METHODS: We conducted a prospective comparative study of 60 eyes of 60 patients presenting with primary pterygium. These patients were divided into two groups, matched according to the age and the stage of the pterygium. Thirty eyes of 30 patients were treated with conjunctival limbal autograft (AGCL group), and 30 eyes of the other 30 patients were treated with simple excision with intraoperative mitomycin C (MMC group). Minimum follow-up was 24 months.
RESULTS: The mean age of our patients was 50.6 and 51.3 years in the AGCL and MMC groups, respectively. A male predominance with male to female ratio of 1.5 was noted in both groups. We found more pterygium recurrences in the MMC group. Indeed, seven patients (23.3%) in the MMC group experienced a recurrence. In comparison, we found only a single recurrence (3.33%) in the AGCL group with a statistically significant difference (P=0.026). With regard to postoperative complications, we noted three inflammatory granulomas in the AGCL group (10%). In the MMC group, we observed two cases (6.66%) of delayed corneal healing with superficial punctate keratitis and epithelial defect and one case (3.33%) of symblepharon. There was no statistically significant difference in mean visual acuity gain between the two groups (AGCL: 1.76 lines; MMC: 2.82 lines; P=0.133).
CONCLUSION: Pterygium surgery by excision with conjunctival limbal autograft is an effective technique offering a low rate of long-term recurrences and few complications.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238071     DOI: 10.1016/j.jfo.2012.03.017

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  5 in total

Review 1.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

2.  In vitro study of cyclosporine A 0.05 % on primary and recurrent pterygium fibroblasts.

Authors:  Magda Massae Hata Viveiros; Fabiano Yutaka Kakizaki; Laura Almeida Hércules; Carlos Roberto Padovani; João Manuel Grisi Candeias; Silvana Artioli Schellini
Journal:  Int Ophthalmol       Date:  2015-08-11       Impact factor: 2.031

3.  Minor ipsilateral simple limbal epithelial transplantation (mini-SLET) for pterygium treatment.

Authors:  Erick Hernández-Bogantes; Guillermo Amescua; Alejandro Navas; Yonathan Garfias; Arturo Ramirez-Miranda; Alejandro Lichtinger; Enrique O Graue-Hernández
Journal:  Br J Ophthalmol       Date:  2015-06-30       Impact factor: 4.638

4.  Recurrence rate with inferior conjunctival autograft transplantation compared with superior conjunctival autograft transplantation in pterygium surgery: a meta-analysis.

Authors:  Wenwei Li; Yaoyong Lou; Bin Wang
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

5.  Simple limbal epithelial transplantation for recurrent pterygium: A case series.

Authors:  Zale Mednick; Tanguy Boutin; Adi Einan-Lifshitz; Nir Sorkin; Allan Slomovic
Journal:  Am J Ophthalmol Case Rep       Date:  2018-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.